FERLAZZO, Edoardo
 Distribuzione geografica
Continente #
NA - Nord America 6.558
AS - Asia 4.378
EU - Europa 2.081
SA - Sud America 1.106
Continente sconosciuto - Info sul continente non disponibili 304
AF - Africa 121
OC - Oceania 19
Totale 14.567
Nazione #
US - Stati Uniti d'America 6.345
SG - Singapore 2.012
CN - Cina 930
IT - Italia 891
BR - Brasile 857
VN - Vietnam 550
IN - India 398
SE - Svezia 245
GB - Regno Unito 193
DE - Germania 188
HK - Hong Kong 131
EE - Estonia 129
CA - Canada 122
AR - Argentina 111
BD - Bangladesh 92
FI - Finlandia 71
NL - Olanda 59
MX - Messico 58
UA - Ucraina 58
ID - Indonesia 53
ZA - Sudafrica 45
IQ - Iraq 44
RU - Federazione Russa 40
FR - Francia 34
EC - Ecuador 32
TR - Turchia 29
ES - Italia 28
CO - Colombia 27
EG - Egitto 27
JP - Giappone 23
PL - Polonia 23
PY - Paraguay 21
CL - Cile 20
AT - Austria 17
PK - Pakistan 17
RO - Romania 16
AU - Australia 15
MA - Marocco 15
CZ - Repubblica Ceca 14
SA - Arabia Saudita 14
GR - Grecia 13
VE - Venezuela 13
PE - Perù 12
CH - Svizzera 11
IE - Irlanda 10
UZ - Uzbekistan 10
UY - Uruguay 9
JO - Giordania 8
IL - Israele 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AE - Emirati Arabi Uniti 6
JM - Giamaica 6
KZ - Kazakistan 6
MD - Moldavia 6
NP - Nepal 6
CI - Costa d'Avorio 5
DZ - Algeria 5
NI - Nicaragua 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
AL - Albania 4
BE - Belgio 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
KE - Kenya 4
KR - Corea 4
LT - Lituania 4
SC - Seychelles 4
TW - Taiwan 4
AZ - Azerbaigian 3
BO - Bolivia 3
DK - Danimarca 3
HN - Honduras 3
KW - Kuwait 3
NG - Nigeria 3
OM - Oman 3
PH - Filippine 3
PT - Portogallo 3
QA - Qatar 3
RS - Serbia 3
TH - Thailandia 3
BG - Bulgaria 2
BY - Bielorussia 2
CR - Costa Rica 2
GA - Gabon 2
GE - Georgia 2
IR - Iran 2
KG - Kirghizistan 2
KH - Cambogia 2
LB - Libano 2
LV - Lettonia 2
MT - Malta 2
MY - Malesia 2
NZ - Nuova Zelanda 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
Totale 14.252
Città #
San Jose 1.106
Dallas 755
Singapore 693
Chandler 544
Ashburn 541
Santa Clara 334
Bengaluru 299
Hefei 288
Milan 275
Council Bluffs 268
Princeton 217
Lawrence 216
Ho Chi Minh City 200
Chicago 165
Munich 141
Wilmington 136
London 134
Beijing 132
Hong Kong 129
Hanoi 115
São Paulo 78
Des Moines 71
Los Angeles 71
Boardman 53
New York 50
Ottawa 49
Rome 48
Shanghai 46
Turku 39
Rio de Janeiro 35
Catanzaro 34
Helsinki 31
Haiphong 27
Da Nang 26
Guangzhou 26
Orem 26
Mexico City 25
Phoenix 23
Chennai 22
Naples 22
Seattle 22
Warsaw 22
Amsterdam 21
San Francisco 20
Atlanta 19
Bari 18
Genoa 18
Johannesburg 18
Redwood City 18
The Dalles 18
Cairo 17
Buffalo 16
Charlotte 16
Norwalk 16
Stockholm 16
Thái Bình 16
Brooklyn 15
Tokyo 15
Columbus 14
Dhaka 14
Toronto 14
Bologna 13
Boston 13
Bắc Ninh 13
Biên Hòa 12
Denver 12
Hải Dương 12
Montreal 12
Pune 12
Quito 12
Brasília 11
Jakarta 11
Olomouc 11
Redmond 11
Santiago 11
Baghdad 10
Buenos Aires 10
Catania 10
Guarulhos 10
Ninh Bình 10
Palermo 10
Shenzhen 10
Tashkent 10
Ankara 9
Belo Horizonte 9
Bogotá 9
Dublin 9
Guayaquil 9
Salvador 9
Suzano 9
Washington 9
Assago 8
Can Tho 8
Curitiba 8
Manchester 8
Montevideo 8
San Nicola Manfredi 8
Amman 7
Aracaju 7
Boydton 7
Totale 8.240
Nome #
Management of psychogenic non-epileptic seizures: a multidisciplinary approach 184
Genetics of reflex seizures and epilepsies in humans and animals 166
Predictive factors of Status Epilepticus and its recurrence in patients with adult–onset seizures: A multicenter, long follow–up cohort study 150
Rating Scale for Psychogenic Non-epileptic Seizures: Scale Development and Clinimetric Testing 149
Epilessia occipitale con FOS in un paziente con calcificazioni cerebrali: studio clinico e video-EEG 148
Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy 146
A comprehensive machine-learning-based software pipeline to classify EEG signals: A case study on PNES vs. control subjects 143
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy 122
A network analysis based approach to characterizing periodic sharp wave complexes in electroencephalograms of patients with sporadic CJD. 103
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study 101
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST) 98
3-T magnetic resonance imaging simultaneous automated multimodal approach improves detection of ambiguous visual hippocampal sclerosis. 96
Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats 92
A Functional Genetic Variation of the 5-HTR2A Receptor Affects Age at Onset in Patients with Temporal Lobe Epilepsy 90
Myoclonic status epilepticus in patients with juvenile myoclonic epilepsy: Case reports and review of the literature 88
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 86
About some behavioral and psychosocial aspects related to epilepsy. 85
A Family With a Complex Phenotype Caused by Two Different Rare Metabolic Disorders: GLUT1 and Very-Long-Chain Fatty Acid Dehydrogenase (VLCAD) Deficiencies 85
Asymmetry of Permutation Entropy in Early Creutzfeldt-Jakob Disease: A Clue to a Specific Pathological Process? 85
Challenges in the pharmacological management of epilepsy and its causes in the elderly. 82
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 81
A commercially available device suppresses photic driving: implications for EEG recording. 80
Lennox-Gastaut syndrome 80
Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational study 79
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 78
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 75
Status epilepticus in pregnancy: a literature review and a protocol proposal 74
A new Italian instrument for the assessment of irritability in patients with epilepsy. 73
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study 72
Peculiar CADASIL phenotype in monozygotic twins carrying a novel NOTCH3 pathogenetic variant 71
Long-term outcome of mild mesial temporal lobe epilepsy 71
Investigating Peri-Ictal MRI Abnormalities: A Prospective Neuroimaging Study on Status Epilepticus, Seizure Clusters, and Single Seizures 69
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 69
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 68
Effectiveness of perampanel as the only add‐on: Retrospective, multicenter, observational real‐life study on epilepsy patients 67
Teaching NeuroImages: Pseudohypertrophic cerebral cortex in end-stage Creutzfeldt-Jakob disease 66
Absence status epilepsy: delineation of a distinct idiopathic generalized epilepsy syndrome. 66
Methodological issues associated with clinical trials in epilepsy 66
Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review 66
Epidemiology and outcomes of status epilepticus 66
Epilepsy in “Sunflower syndrome”: electroclinical features, therapeutic response, and long-term follow-up 66
When the practice does not meet the evidence: An Italian survey on the use of antiseizure medications in routine neurosurgery practice 65
Provocative techniques for functional/dissociative seizure: the colored pad test – a safe and reliable procedure 65
Dystonia in Angelman syndrome: a common, unrecognized clinical finding 65
Therapeutic approach to neurological manifestations of Angelman syndrome 64
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study 64
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy. 64
Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors 64
Deep learning representation from electroencephalography of early-stage creutzfeldt-jakob disease and features for differentiation from rapidly progressive dementia 64
Deep Learning Representation from Electroencephalography of Early-Stage Creutzfeldt-Jakob Disease and Features for Differentiation from Rapidly Progressive Dementia. 63
Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsy 63
Functional seizures and binge eating disorder: A cross-sectional study 62
Autosomal dominant lateral temporal epilepsy: absence of mutations in ADAM22 and Kv1 channel genes encoding LGI1-associated proteins. 62
Analysis of LGI1 promoter sequence, PDYN and GABBR1 polymorphisms in sporadic and familial lateral temporal lobe epilepsy 62
An Italian multicentre study of perampanel in progressive myoclonus epilepsies 62
Clinical utility of home videos for diagnosing epileptic seizures: a systematic review and practical recommendations for optimal and safe recording 62
The hidden link between late-onset seizures and cerebral amyloid angiopathy: A case-control study 61
Integrity of the corpus callosum in patients with benign temporal lobe epilepsy 61
Therapeutic approach to difficult-to-treat typical absences and related epilepsy syndromes 61
Gestural automatisms during syncope related to cervical malignancy 60
A Reappraisal on cortical myoclonus and brief Remarks on myoclonus of different Origins 59
An educational campaign about epilepsy among Italian primary school teachers. 2. The results of a focused training program. 59
Familial idiopathic generalized epilepsy: description of an unusual phenotype in a family. 59
Predictors of Seizure Recurrence in Women With Idiopathic Generalized Epilepsy Who Switch From Valproate to Another Medication 59
Array-CGH in pazienti con epilessia e ritardo mentale 58
Profile of brivaracetam and its potential in the treatment of epilepsy 58
Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcome 58
Late-onset fabry disease due to the p.Phe113Leu variant: the first italian cluster of five families 57
Investigation into the casual or causal association of cerebral venous thrombosis and myelin oligodendrocyte glycoprotein antibody‑associated disease: A case report and literature review 57
Polymorphism of the multidrug resistance 1 gene MDR1/ABCB1 C3435T and response to antiepileptic drug treatment in temporal lobe epilepsy 57
Effectiveness of Perampanel as the Only Add-on: Retrospective, Multicenter, Observational Real Life Study on epilepsy patients 56
Insights into the Genetic Profile of Two Siblings Affected by Unverricht-Lundborg Disease Using Patient-Derived hiPSCs 55
Autosomal recessive progressive myoclonus epilepsy due to impaired ceramide synthesis. 55
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) 54
Permutation entropy of scalp EEG: A tool to investigate epilepsies: Suggestions from absence epilepsies. 54
Botulism-induced unilateral submandibular sialoadenitis: a case report. 54
Functional convergence spasm: An unexpected finding in a patient with focal epilepsy 54
Topiramate ban in women of childbearing potential with idiopathic generalized epilepsy: Does effectiveness offset the teratogenic risks? 53
Generation of human induced pluripotent stem cell lines (UNIMGi003-A and UNIMGi004-A) from two Italian siblings affected by Unverricht-Lundborg disease 53
Seizures When Exiting a Bath: A Rare Type of Reflex Epilepsy 52
Alien hand syndrome-like functional seizures in a patient with right temporo-parietal damage and neurocognitive disorder: a case report 52
Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis 52
Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) 52
A pilot open-label trial of zonisamide in Unverricht-Lundborg disease. 52
Connectivity measures suggest a sub-cortical generator of myoclonus in Angelman syndrome 52
Incidence of early poststroke seizures during reperfusion therapies in patients with acute ischemic stroke: An observational prospective study: (TESI study: “Trombolisi/Trombectomia e crisi Epilettiche precoci nello Stroke Ischemico”) 52
Establishment and characterization of induced pluripotent stem cells (iPSCs) from central nervous system lupus erythematosus 52
Variable course of Unverricht-Lundborg disease 52
Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy 52
Utility and limitations of homemade videos in differentiating functional seizures from other paroxysmal events: An Italian cohort study 51
Second-Line Medications for Women Aged 10 to 50 Years with Idiopathic Generalized Epilepsy 51
EpiNet as a way of involving more physicians and patients in epilepsy research: Validation study and accreditation process. 51
The journey of a floating fat: from suprasellar dermoid cyst to lateral ventricles 51
No evidence of a role for cystatin B gene in juvenile myoclonic epilepsy. 51
Lennox-GAstaut Syndrome in patients older than 40: clinical and EEG features 51
Management of status epilepticus in patients with liver or kidney disease: a narrative review 51
Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study 50
Normal immunofluorescence pattern of skin basement membranes in a family with porencephaly due to COL4A1 G749S mutation 50
Value of clinical features to differentiate refractory epilepsy from mimics: a prospective longitudinal cohort study. 50
The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a “real world” context: focus on temporal lobe epilepsy 50
Totale 7.142
Categoria #
all - tutte 133.504
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.504


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022653 0 2 11 170 72 8 12 148 58 59 111 2
2022/20231.642 438 27 60 154 174 164 8 116 258 111 112 20
2023/2024807 147 113 69 61 55 161 31 33 22 22 25 68
2024/20253.143 405 251 153 136 153 418 93 85 355 270 281 543
2025/20267.419 313 693 1.125 1.422 629 229 824 438 903 507 237 99
2026/2027542 105 437 0 0 0 0 0 0 0 0 0 0
Totale 14.567